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A B S T R A C T
We evaluated the effect of vagus nerve stimulation (VNS) on interictal epileptiform discharges (IEDs) in
32 epileptic patients (18 females; 14 males) with an average age of 42.2  11.4 years, all of whom had
been suffering from epilepsy for an average of 29.2  14.5 years. All of the patients had received VNS for 5
years. The ﬁrst EEGwas performed prior to the initiation of stimulation; the second EEGwas performed at the
5-year follow-up visit. The duration of each EEG was 30 min. We compared these two EEGs in terms of the
number of IEDs present in each patient and correlated them to other variables.
The average total number of IEDs during EEG and the total number of seconds in which IEDs were
present decreased signiﬁcantly after 5 years of stimulation from 97.3  106.9 resp. 80.6  86.1 to
49.4  94.0 resp. 37.8  65.0. Although there was no positive correlation between the reduction of IEDs and
the percent of seizure reduction, we found a greater decrease of IEDs in patients who responded to VNS in
comparison to those who did not. The decrease of IEDs was more pronounced in patients suffering from
temporal lobe epilepsy than in patients suffering from extratemporal epilepsy. No other signiﬁcant
correlations were found.
VNS reduced IEDs in patients chronically simulated for epilepsy. The reduction of IEDs was greater in
patients who responded to VNS and in patients suffering from temporal lobe epilepsy.
 2010 Published by Elsevier Ltd on behalf of British Epilepsy Association.
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Vagus nerve stimulation (VNS) is a non-pharmacological
treatment for epilepsy. Literature generated in recent years has
shown that VNS is a safe, tolerable, and effective adjunctive
therapy for patients with refractory epilepsy. Its effectiveness was
demonstrated both in controlled and in open-label trials.1–5
Pilot experimental data on animal models showed that VNS
may have different effects on EEG and interictal epileptiform
discharges (IEDs).6–9 High-intensity and high-frequency vagal
stimulation produces desynchronization in cortical EEG in animal
models, and lower intensity stimulation at the same rate causes
synchronization.6,7
Human data showed different effects of IEDs during both acute
and chronic VNS. The initial data obtained from adult patients with
refractory epilepsy did not reveal any signiﬁcant changes of IEDs or
any changes in the frequency power spectrum.10,11
Koo demonstrated the reduction of IEDs and improvement of
interictal EEG in adult patients suffering from both focal and* Corresponding author. Tel.: +420 543 182 626; fax: +420 543 182 624.
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doi:10.1016/j.seizure.2010.05.009generalized seizures.12 Other studies conﬁrmed this data in both
adults and children with various types of epilepsies and seizures
including epileptic encephalopathies.13–15 Two of these studies
demonstrated a signiﬁcant correlation between the percent of
seizure reduction and the reduction of IEDs.13,15
We conducted our study on 32 patients suffering from refractory
epilepsy. All of themwere treatedwithVNS for 5 years to determine
whether chronic VNS inﬂuences IEDs and whether there are
potential correlationsbetween thiseffect andother clinical variables
(etiology, age of seizure onset, duration of epilepsy, percent of
seizure reduction after 5 years of VNS, responder rate, and effect of
on-demand magnetic extrastimulation).
2. Methods
We performed a retrospective, explorative, monocentric trial to
explore the effect of chronic VNS on IEDs. We included all of the
patients in our clinic who had completed 5 years of VNS between
April 2004 and April 2008.
Thirty-two epileptic patients (18 females, 14 males) with an
average age of 42.2  11.4 years, all of whom had been suffering
from epilepsy for an average of 29.2  14.5 years, participated in the
study. VNS therapy had been recommended by a special committee of
the Brno Epilepsy Center. None of the patientswho receivedVNSwere
considered to be a suitable candidate for resective surgery. All of theEpilepsy Association.
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video-EEG monitoring, magnetic resonance imaging, neuropsycho-
logical assessment, interictal FDG positron emission tomography in
all patients; interictal and/or ictal HMPAO single photon emission
tomography, and Wada tests in patients where applicable). A VNS
device (Cyberonics Inc., models 100 and 101 NCP, Houston, TX, USA)
was implanted. A standard surgical technique was used to implant
the VNS device.14,15 All of the patients were implanted with the VNS
device 5 years prior to the beginning of this study, and intermittent
stimulation of the vagal nerve started on the day of implantation.
Informed consent was obtained from each patient prior to the study,
and the study received the approval of the St. Anne’s Hospital Ethics
Committee.
2.1. Stimulation characteristics
The following stimulation parameters of chronic VNS were
applied at the time of the study: a 20 Hz frequency in 30 patients,
30 Hz in 2 patients; a pulse width of 250ms in all patients; a 30 s/
5 min on/off cycle was used in 5 patients, 21 s/3 min in 9 patients,
21 s/1.8 min in 6 patients, 30 s/1.8 min in 8 patients, 30 s/3 min in 2
patients, and 30 s/1.8 min in 2 patients. The output current ranged
from 1.00 to 2.00 mA, with an average of 1.56  0.29 mA. The
magneticparameterswereadjusted inall subjects forextrastimulation.
The values of this output current were 0.25 mA higher that of the
intermittent stimulation in each subject; the other parameters for the
extrastimulation were identical to those mentioned above.
2.2. Clinical characteristics
We collected data from each patient concerning the etiology of
epilepsy, seizure type, localization of epilepsy, and any previous
epilepsy surgery procedures.
2.3. EEG analysis
The 32-channel Brain Quick system (Micromed), using a 10-20
system, was used for scalp recording. EEG was ampliﬁed with a
bandwidth of 0.4–100 Hz, at a sampling rate of 128 Hz. No seizures
were noted (neither by the patients themselves nor by their
caregivers) for at least 24 h prior to the EEG analysis or during the
entire EEG procedure in any of the subjects. We performed two
EEGswithout either photic stimulation or hyperventilation, both at
the same approximate time of day (between 10 a.m. and 1 p.m.).
Each EEG lasted at least 30 min for each patient, during which the
patient lay in a supine position, with closed eyes. Vigilance was
evaluated continuously by experienced nursing staff on the basis of
the character of the EEG curve. The EEG recording lasted usually
more than 30 min; we excluded any periods with signiﬁcant
artifacts and included only 30 min of recording free of artifacts. The
ﬁrst EEGwas administered 1–3months prior to the implantation of
the VNS device, and the second EEG after 5 years of stimulation.
The EEG for all of the patients was visually analyzed. Only
deﬁnite spikes, sharp waves, and spike-wave complexes were
considered epileptiform abnormalities; their shapes were distin-
guished by morphology and/or amplitude from the background
activity. Nonepileptogenic or uncertain sharp discharges were not
considered signiﬁcant. Both focal and generalized IEDs were
always included in the analysis. Two people analyzed the EEG. We
did not assess inter-observer reliability. Only the epileptic
graphoelements that both observers agreed on were included in
the analysis. Both authors who analyzed the EEGs were aware of
each patient’s outcome, but were blinded at the time of their
review to which patient’s EEG they were reviewing.
We visually analyzed two different paradigms: the absolute
number of IEDs in each 30-min EEG and the number of seconds inwhich IEDs were present. Both analyses were included in the
statistical analysis.
For each patient, we counted the ratio RIED—the ratio of the
number of IEDs in the preoperative EEG and in the EEG at the 5-
year follow-up (RIED = IEDpreop/IED5 year). We also counted the ratio
RSEC—the ratio of the number of seconds in which IEDs were
present in the preoperative EEG and in the EEG at the 5-year
follow-up visit (RSEC = SECpreop/SEC5 year). This ratio was then
calculated as a percentage, treating the baseline IEDpreop as 100%.
RIED and RSEC were compared and correlated with other
variables (etiology, age of seizure onset, duration of epilepsy,
percent of seizure reduction after 5 years of VNS, responder rate,
and effect of on-demand magnetic extrastimulation). The data
collected for this studywere based on the patients’ ﬁles and seizure
diaries. The monthly seizure frequency was evaluated from
patients’ seizure diaries at the preoperative visit and at the 5-
year follow-up visit (the day of second EEG). The mean monthly
seizure frequency at baseline and at the last follow-up visit was the
mean seizure frequency of the previous 6 months.
2.4. Statistical analysis
The Wilcoxon rank test was used to compare the absolute
number of IEDs and the number of seconds in which IEDs were
present, preoperatively and after 5 years of stimulation. The
Mann–Whitney U test was used to compare RIED and RSEC in the
groups of patients with different etiology, localization of epilepsy,
effect of magnetic extrastimulation, and responder rate. The
Spearman rank correlation test was used to calculate the
correlation between RIED and RSEC and the ages of the patients,
duration of epilepsy, age of epilepsy onset, and the percent of
seizure reduction. SPSS 13.0 was used to perform the statistical
analysis. p < 0.05 was considered to be statistically signiﬁcant.
3. Results
3.1. Clinical characteristics
Symptomatic etiology was revealed in 23 patients; cryptogenic
etiology was revealed in 9 patients. No patient suffered from
idiopathic generalized epilepsy. The cause of the epilepsy was
established as mesiotemporal sclerosis in 6 patients, and as some
type of malformation of cortical development in 5 patients.
Perinatal lesions were found in 4 patients, postencephalitic lesions
in 3 patients, glioma and angioma occurred in 2 patients each, and
diffuse posttraumatic lesions in both hemispheres occurred in 1
patient.
Sixteen patients suffered from temporal lobe epilepsy (TLE) and
16 patients from extratemporal epilepsy (exTLE) (5 patients—
frontal lobe epilepsy, 1 patient—parietal lobe epilepsy, 7 patients—
probable multilobar ictal onset, 3 patients—undetermined ictal
onset). Focal seizures with or without secondary generalization
occurred in 28 patients; generalized tonic–clonic seizures without
any clear focal onset occurred in 4 patients. Previous unsuccessful
resection surgery to treat the epilepsy had been performed in 4
patients (tailored lesionectomy in 3 patients; antero-medial
temporal lobe resection in 1 patient). Partial anterior callosotomy
had been performed in 3 patients.
3.2. Efﬁcacy of VNS
The average number of all seizures at the baseline, i.e. prior to
the implantation of VNS; in all patientswas 34.5  40.2 seizures per
month. At the 5-year follow-up, the average number of all seizures,
regardless of seizure type, dropped to 6.8  8.9 seizures per month.
The average percent seizure reduction after 5 years of VNS in all 32
Table 1
Average RIED and RSEC in responders and nonresponders to chronic VNS. Statistically
signiﬁcant differences are indicated by *.
Responders Nonresponders Statistics
Average RIED 0.590.61 0.97 0.99 Z=1.99; p=0.039*
Average RSEC 0.540.46 0.95 0.82 Z=1.92; p=0.042*
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were seizure-free, 7 patients (21.8%) had90% seizure reduction, and
the other 12 responding patients (37.5%) had50% seizure reduction.
In total, 22 patients (68.7%) reached50% seizure reduction andwere
classiﬁed as responders, and 10 patients (31.3%) were classiﬁed as
nonresponders.
We noted the positive effect ofmagnetic extrastimulationwhen
used (either by the patients themselves or by a caregiver) in
abolishing >50% seizures in 11 out of 32 patients (34.4%).
3.3. EEG analysis; IEDs
The total number of IEDs during EEG prior to the implantation
ranged from 0 to 330 IEDs (average of 97.3  106.9; median of 49).
The number of seconds in which IEDs were present, at that time,
ranged from 0 to 315 s (average of 80.6  86.1; median of 37) per 30-
min EEG procedure. The total number of IEDs during EEG at the 5-year
follow-up ranged from 0 to 447 IEDs (average of 49.4  94.0; median
of 19.5). The number of seconds in which IEDs were present, at the 5-
year follow-up, ranged from 0 to 294 s (average of 37.8  65.0;
median of 16.5) per 30-min EEG procedure. The decrease in the total
number of IEDs and the number of seconds in which IEDs were
present at the 5-year follow-up visit in comparison to pre-
implantation was statistically signiﬁcant according to the results of
the Wilcoxon rank test.
RIED  0.5 (i.e. at least 50% reduction of the number of IEDs) was
present in 13 out of 32 patients (40.6%); similarly, RSEC  0.5 (i.e. at
least 50% reduction of seconds in which IEDs were present) was
noted in the same 13 patients.
There were signiﬁcant differences between responders and
nonresponders in terms of average RIED and RSEC. Average RIED and
RSEC were signiﬁcantly lower in patients who responded to VNS in
comparison to patients who did not (0.59  0.61 and 0.54  0.46 in
responders); 0.97  0.99 and 0.95  0.82 in nonresponders (Table 1).
Both average RIED and RSEC was signiﬁcantly lower in patients
suffering from TLE in comparison to patients suffering from exTLE
(0.56  0.59 and 0.52  0.56 in TLE; 0.85  0.88 and 0.77  0.76 in
exTLE). Therewere no signiﬁcant differences between these groups in
terms of the number of responders and the average seizure reduction.
In conclusion, EEG improvement was signiﬁcantly more pronounced
in patients with TLE than in those with exTLE (Table 2).
There were no signiﬁcant correlations between RIED and RSEC
and percent seizure reduction.
Neither RIED nor RSEC signiﬁcantly correlated with the age of
patients, the duration of epilepsy, or the age of epilepsy onset.
There were no differences in either the average RIED or the average
RSEC between the patients with symptomatic and the patients withTable 2
Average RIED and RSEC in patients with different responses to magnetic extrastimulation. D
are indicated by *.
Magnetic extrastimulation Etiolog
Positive effect Negative Effect Crypto
Average RIED 0.57 0.48 0.89 0.92 0.94
Statistic Z=0.854, p=0.41 Z=1.82
Average RSEC 0.54 0.44 0.79 0.78 0.84
Statistic Z=0.71, p=0.47 Z=1.55cryptogenic etiology of epilepsy, or between the patients who
responded positively to magnetic extrastimulation in comparison
to patients who did not (Table 2).
4. Discussion
Our study clearly demonstrated that VNS has an effect on the
frequency of IEDs in patients chronically treated by VNS. We can
conclude that VNS positively affects the interictal EEG regardless of
the seizure frequency. However, we should stress that about two-
thirds of our patients were responders and that the average
percent seizure reduction after 5 years reached 69.4% in our
patients. In contrast to the results of our study, early data from
human testing did not demonstrate any signiﬁcant effect of VNS on
interictal EEG regardless of seizure outcome. These studies were
performed on refractory adult patients. In addition to the lack of
effect on EEG, the earlier EEG tests of VNS did not reveal any effect
on ictal epileptiform activity and normal EEG rhythms.10,11 Other
studies reported the chronic effect of VNS on EEG. The most cited
study by Koo12 demonstrated the positive effect of chronic VNS on
EEG in 21 patients. Koo demonstrated a progressive increase in the
duration of spike-free intervals and a progressive decrease in the
duration and frequency in IEDs in 5 patients with numerous IEDs
on baseline EEG. The other 16 patients also showed a statistically
signiﬁcant progressive decrease in the number of IEDs over time.12
Our study cannot provide data concerning gradual changes in EEG
over time, because we performed only two EEGs in 5 years.
However, our analysis has demonstrated the positive effect of VNS
in EEG results for twice as many patients and over a longer period
of time. More recently published studies performed on children
with refractory epilepsy, including severe childhood epilepsies,
also reported a signiﬁcant reduction of spikes over a period of time
(up to 2-year follow-up).13,14 Most recently, Wang et al. reported
the positive effect of long-term VNS on IEDs in a small series of 8
patients with refractory epilepsy.15
We did not demonstrate a clear correlation between the percent
of seizure reduction and the reduction of IEDs after 5 years of VNS,
but we observed a signiﬁcantly greater reduction in IEDs in
patients who responded to VNS than in those who did not. Similar
results are mentioned relatively rarely in the literature. Ebus et al.
reported a signiﬁcant correlation between spike rate and seizure
frequency in 19 children with severe childhood epilepsies, mostly
Lennox–Gastaut syndrome.13 Wang et al. demonstrated a similar
correlation in 8 adult patients with refractory epilepsy.15
Explanations for the different results concerning the inﬂuence
of VNS on interictal EEG remain speculative. While the ﬁrst human
data in the early 1990s showed no substantial effect, some studies
published in the last 8 years have provided positive results. Two
explanations are probable. The earlier studies included a smaller
number of patients than the more recent studies, and the duration
of stimulation was much longer in the more recent studies. While
in the pilot studies, the duration of stimulation did not exceed 1
year,10,11 the EEG was evaluated after 1 year in other studies,12,13
and after 5 years of stimulation in our study. Delayed EEG changes
in our study and othermore recent studies are similar to the resultsifferent etiology and localization of epilepsy and statistically signiﬁcant differences
y of epilepsy Localization of epilepsy
genic Symptomatic Temporal Extratemporal
0.23 0.720.93 0.560.59 0.77 0.76
3, p=0.071 Z=1.912, p=0.043*
0.27 0.650.79 0.520.56 0.85 0.88
, p=0.122 Z=1.889, p=0.046*
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a chronic modulation of brain synaptic activity, although the
precise mechanism of action is unknown. Hypothetically, the
longer the modulation, the more pronounced the effect, both on
the clinical status and on the EEG. A progressive decline in the
number of epileptic seizures and an increased number of patients
who responded to VNS was repeatedly demonstrated in the
literature.4,5,17–19
Our study showed that there was a greater reduction of IEDs in
both measurements in patients with TLE in comparison to those
with exTLE without reference to responder rate. The different
effect of VNS on EEG in different epileptogenic zones has not yet
been discussed in the literature. The explanation of this result is
hypothetical. The number of studies using functional imaging
techniques, such as single photon emission tomography (SPECT)
and positron emission tomography (PET), have demonstrated
widespread changes in blood ﬂow and metabolism in several
cortical and subcortical regions during acute VNS.20–22 The
changes were most prominent in the thalamus, postcentral region,
and in various parts of limbic system (amygdala, hippocampus,
cingulate gyrus). VNS may preferentially inﬂuence the limbic
system structures including the temporal lobe. Nevertheless, no
studies stressed a better effect of VNS in TLE in comparison to
exTLE.
Although there are different data concerning the EEG changes in
chronic VNS patients, our study, performed on the highest number
of patients and with a long-term outcome, clearly demonstrated
that there was a signiﬁcant improvement in the interictal EEG in
patients chronically treated with VNS. The effect on EEG is
emphasized in those patients who respond to chronic stimulation
and in patients suffering from TLE. Further studies analyzing the
consecutive EEGs after VNS should be performed to evaluate the
changes of EEG caused by VNS over a period of time.
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